Inozyme Pharma, Inc. — Form D

Inozyme Pharma, Inc. of BOSTON, MA, a company, filed a Form D exempt-offering notice with the SEC on 2017-01-05. Industry: Pharmaceuticals.

Offering

Filed: 2017-01-05
Form: D
Accession: 0001693011-17-000002
Industry: Pharmaceuticals
Exemptions: 06b
Security types: equity
Revenue range: No Revenues
SEC file number: 021-277738

Issuer

Name: Inozyme Pharma, Inc.
CIK: 0001693011
Entity type: Corporation
Jurisdiction: DELAWARE
Incorporated: 2015
Address: 321 Summer Street, BOSTON, MA, 02210
Phone: 857-330-4340

Officers, directors & promoters (11)

Name	Role	Location
Edward Mathers	Director	South San Francisco, CA
Rob Hopfner	Director	San Diego, CA
DOUGLAS TRECO	Director	WINCHESTER, MA
Lynne Sullivan	Director	Ness Ziona, L3
Sarah Bhagat	Director	MENLO PARK, CA
Joseph Schlessinger	Director	Woodbridge, CT
Joseph Schlessinger	Executive Officer	Woodbridge, CT
Reinaldo Diaz	Director	Boston, MA
Martin Edwards	Director	Boston, MA
Axel Bolte	Director	Boston, MA
Axel Bolte	Executive Officer	Boston, MA

Other filings by this issuer (6)

Filed	Form	Offering	Sold
2020-06-08	D/A	$67.4M	$67.4M
2020-03-27	D/A	$33.7M	$33.7M
2019-03-29	D/A	$33.7M	$33.7M
2018-11-21	D	$10.7M	$10.7M
2018-11-21	D/A	$48.9M	$48.9M
2017-01-12	D/A	—	—

More